{"id":"W4281722441","doi":"10.1007/s11523-022-00884-z","title":"A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study","year":2022,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Boehringer Ingelheim","keywords":"Medicine; Afatinib; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Neratinib; Cancer; Epidermal growth factor receptor; Breast cancer; Clinical trial; Erlotinib; Phases of clinical research; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002510458,0.0001435063,0.0004946864,0.0002228886,0.0001372912,0.000008243514,0.0004163508,0.00005549452,0.0006613979],"category_scores_gemma":[0.0002563814,0.00008481225,0.00005398884,0.0007316454,0.0002081671,0.00003737838,0.0001551904,0.000875572,0.000006332511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006614012,"about_ca_system_score_gemma":0.001222755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008565953,"about_ca_topic_score_gemma":0.001022864,"domain_scores_codex":[0.996179,0.001899615,0.0005330911,0.0003248538,0.0006845536,0.0003788231],"domain_scores_gemma":[0.9985084,0.0005567675,0.00017357,0.0006203688,0.00008485038,0.00005604618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1988132,0.08735282,0.6199746,0.00008722726,0.0003573895,0.0004243444,0.07346888,0.001014582,0.0024229,0.0000929484,0.008171339,0.007819805],"study_design_scores_gemma":[0.2078932,0.05190501,0.7054503,0.00001771944,0.00008770936,0.000004907346,0.02772318,0.0005094949,0.00007277742,0.00006678484,0.006107938,0.0001609554],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906309,0.00007477202,0.000003218423,0.001651134,0.0001986003,0.006330674,0.00006467061,0.00001350108,0.001032507],"genre_scores_gemma":[0.9966329,0.000004027884,0.0000513598,0.0006831027,0.00006991305,0.0024321,0.00003854327,0.00002430003,0.00006375035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08547573,"threshold_uncertainty_score":0.7241843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06037269198487216,"score_gpt":0.3976504848924063,"score_spread":0.3372777929075341,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}